about
Diagnostic biomarkers in multiple sclerosis.Magnetic resonance imaging in neuromyelitis optica.Neuromyelitis optica spectrum disorders associated with other autoimmune diseases.Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis.Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literatureTherapeutic plasma exchange in neuromyelitis optica: a case series.Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation.The growing spectrum of antibody-associated inflammatory brain diseases in children.Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.Interferon alpha association with neuromyelitis optica.Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imagingClinical biomarkers in multiple sclerosis.Interferons in the central nervous system: a few instruments play many tunes.Marked hypotonia in an infant of a mother with Devic disease.New onset neuromyelitis optica in a young Nigerian woman with possible antiphospholipid syndrome: a case report.Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children.The impact of neuromyelitis optica on the recognition of emotional facial expressions: a preliminary report.A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.
P2860
Q30598338-710ACE4B-361D-4385-8AC9-29B54AF98C0EQ30820823-5D0A6108-B13D-4F68-BE5A-3262030D7D82Q30832651-B1B1D520-B518-48F2-A472-D38EFC15EC4AQ33656297-1EC889FD-1E19-459D-9613-525397BA8E62Q33669418-0E3AB58B-7457-41B1-A586-2D18BC82DB42Q34320394-6FA1B3BD-434F-4DEC-ABF7-71B945C2AF92Q34378423-45522B70-0474-413B-8D95-8C09B24AA124Q34813295-D90C56C3-4BBF-470C-B117-5D7F835B5079Q35441181-39459833-EC91-464D-9B64-297960E58B41Q35949316-9196ABAD-0CAD-48FB-B24F-16DB16AD464CQ37375268-EA6E0216-6B36-4EDC-9231-DD91501B3B57Q37442228-9711BC7B-22EB-4D7D-80DB-EAF4D9E7B1EDQ38088728-1B5D5799-3DED-4DAE-9EE5-692807E0E7DAQ38192651-7F979459-A24A-456F-AFB9-C5218C74B055Q43211373-3D377F75-DEA3-4E46-9E60-7E201A934183Q43229815-B39CE611-EB59-4C81-B8F7-D77CAD53C3E6Q45307861-09A94B43-6FE6-4B78-86E0-E9FE3D5F198EQ46491693-2BCF6E65-9968-4A77-952F-2469E3AB68DFQ47848669-829E4F8C-5B65-40CB-833A-A0467714772EQ55107890-E3E1F907-AD62-46CB-B74B-70626F4286C1
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
NMO-IgG: a specific biomarker for neuromyelitis optica.
@ast
NMO-IgG: a specific biomarker for neuromyelitis optica.
@en
type
label
NMO-IgG: a specific biomarker for neuromyelitis optica.
@ast
NMO-IgG: a specific biomarker for neuromyelitis optica.
@en
prefLabel
NMO-IgG: a specific biomarker for neuromyelitis optica.
@ast
NMO-IgG: a specific biomarker for neuromyelitis optica.
@en
P2093
P921
P356
P1433
P1476
NMO-IgG: a specific biomarker for neuromyelitis optica.
@en
P2093
Brian G Weinshenker
Claudia F Lucchinetti
Dean M Wingerchuk
Sean J Pittock
Vanda A Lennon
P304
P356
10.1155/2006/586306
P577
2006-01-01T00:00:00Z